Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval

Saved in:
Bibliographic Details
Published in:Clinical Ophthalmology
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1869119582131716097
collection WordPress RSS
FRELIP Feed Integration
container_title Clinical Ophthalmology
description
discipline_display Ophthalmology and Optometry
discipline_facet Ophthalmology and Optometry
format Online Article
RSS Article
genre Journal Article
id rss_article:96193
institution FRELIP
journal_source_facet Clinical Ophthalmology
last_indexed 2026-06-27T03:35:39.566Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval
Ophthalmology and Optometry
General
Ophthalmology and Optometry
sub_discipline_display General
sub_discipline_facet General
subject_display Ophthalmology and Optometry
General
Ophthalmology and Optometry
subject_facet Ophthalmology and Optometry
General
Ophthalmology and Optometry
title Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval
title_alt Suspensión de la terapia anti-VEGF en pacientes con degeneración macular neovascular relacionada con la edad que permanece inactiva con tratamiento en el intervalo máximo de inyección
Arrêt du traitement anti-VEGF chez les patients atteints de dégénérescence maculaire liée à l'âge néovasculaire qui reste inactive avec un traitement à l'intervalle d'injection maximal
Descontinuação da Terapia Anti-VEGF em Pacientes com Degeneração Macular Neovascular Relacionada à Idade que Permanece Inativa com Tratamento no Intervalo Máximo de Injeção
title_auth Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval
title_es_txt Suspensión de la terapia anti-VEGF en pacientes con degeneración macular neovascular relacionada con la edad que permanece inactiva con tratamiento en el intervalo máximo de inyección
title_fr_txt Arrêt du traitement anti-VEGF chez les patients atteints de dégénérescence maculaire liée à l'âge néovasculaire qui reste inactive avec un traitement à l'intervalle d'injection maximal
title_full Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval
title_fullStr Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval
title_full_unstemmed Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval
title_pt_txt Descontinuação da Terapia Anti-VEGF em Pacientes com Degeneração Macular Neovascular Relacionada à Idade que Permanece Inativa com Tratamento no Intervalo Máximo de Injeção
title_short Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval
title_sort discontinuing anti-vegf therapy in patients with neovascular age-related macular degeneration that remains inactive with treatment at the maximum injection interval
topic Ophthalmology and Optometry
General
Ophthalmology and Optometry
url https://www.dovepress.com/discontinuing-anti-vegf-therapy-in-patients-with-neovascular-age-relat-peer-reviewed-fulltext-article-OPTH